GlassScriptPhysician profile
Ashley Judd Smith
NPI 1295403616
$1,348.67
in general payments reported to CMS, 2019-2025
28 companies · $216 in 2025
The $216 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $54.23 · 2022: $288 · 2023: $463 · 2024: $327 · 2025: $216.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $865 · Travel and Lodging: $141.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $865.30 |
| Travel and Lodging | $141.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $282.48 | 2021-2025 | |
| Lilly USA, LLC | $212.71 | 2022-2024 | Mounjaro, Jardiance, Trulicity |
| Merit Medical Systems INC | $141.17 | 2023 | Rad Bd Xtra, Rad Trac, Rad Board |
| Boehringer Ingelheim Pharmaceuticals, INC. | $89.04 | 2022-2025 | Jardiance |
| Abbott Laboratories | $88.23 | 2024 | Freestyle Libre 3 |
| Dynavax Technologies Corporation | $66.93 | 2022-2025 | Heplisav-B |
| Corium, LLC | $53.88 | 2024 | Azstarys |
| Glaxosmithkline, LLC. | $34.89 | 2022-2023 | Arexvy, Shingrix |
| Organon LLC | $31.18 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $31.12 | 2022 | |
| Idorsia Pharmaceuticals US INC | $27.20 | 2022-2023 | Quviviq |
| Cranial Technologies, INC | $25.69 | 2022-2023 | Doc Band |
| Gilead Sciences, INC. | $22.99 | 2023 | |
| Radius Health, INC. | $20.27 | 2025 | Tymlos |
| Viiv Healthcare Company | $19.77 | 2025 | Apretude |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $19.62 | 2025 | |
| Boston Scientific Corporation | $17.83 | 2024 | |
| Ultragenyx Pharmaceutical INC. | $17.04 | 2022 | |
| Sonex Health, INC. | $16.65 | 2025 | Sx-One Microknife |
| Astellas Pharma US INC | $16.28 | 2025 | Veozah |
| Seqirus USA INC | $15.78 | 2025 | Fluad, Flucelvax |
| Novo Nordisk INC | $15.27 | 2025 | Rybelsus, Ozempic |
| Biohaven Pharmaceuticals, INC. | $14.74 | 2021 | |
| Medtronic, INC. | $14.18 | 2025 | Inceptiv |
| Hologic Sales and Service, LLC | $13.88 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $13.37 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $13.28 | 2023 | Breztri |
| Axonics, INC. | $13.20 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.